UBS trims target but Bunge Global stock stays supported by strong 2026 earnings

Published on 09/10/2026 at 15:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UBS cut its price target on Bunge Global stock to USD 115 on September 10, 2026 while keeping a Buy rating after strong recent gains. The shares reflect Q2 2026 results with adjusted EPS of USD 2.00 and revenue of USD 24.04 billion beating Wall Street forecasts.

Drei Mähdrescher ernten Sojabohnenfeld bei Sonnenuntergang, Silos im Hintergrund — Bunge Global SA US12185T1043 zeigt Mähdrescher bei der Sojabohnenernte im Mittleren Westen, Illustration mit AI erstellt.

Bunge Global SA stock (ISIN US12185T1043) is trading in the low USD 120s after a sharp run-up, and fresh analyst moves on September 10, 2026 underline that the story is now about valuation rather than growth stalling. According to Investing.com on September 10, 2026, UBS lowered its price target on Bunge Global from USD 145 to USD 115 while maintaining a Buy stance, as the shares have climbed 54 percent over the past year.

Analysts recalibrate targets after strong rally

The UBS adjustment is the most visible catalyst for Bunge Global stock this week, with the bank explicitly citing valuation as the reason for cutting its target to USD 115 while keeping a positive recommendation. As Investing.com reports on September 10, 2026, the new target sits near the lower end of an analyst consensus range between USD 116 and USD 150, compared with a current share price around USD 123.50, which is up 54 percent over the past 12 months.

Other houses are sticking to more ambitious levels. According to Investing.com on September 10, 2026, Texas Capital Securities reiterated a Buy rating with a price target of USD 150, while BMO Capital continues to rate the shares Outperform, also with a USD 150 target. A MarketBeat overview notes that the broader analyst community assigns Bunge Global a consensus rating of Moderate Buy with a consensus price target of USD 132.67, providing a middle ground between UBS and the more optimistic houses, as reported by MarketBeat on September 10, 2026.

Q2 2026 results beat expectations and support guidance

The analyst debate is anchored in a set of solid operating figures. Bunge recently reported second-quarter 2026 results that beat Wall Street forecasts. As Investing.com summarizes, adjusted earnings per share in Q2 2026 came in at USD 2.00, ahead of the Wall Street consensus of USD 1.95, a positive surprise of about 2.6 percent. In the same quarter, revenue reached USD 24.04 billion, exceeding analyst expectations of USD 23.38 billion by roughly USD 0.66 billion.

Alongside the beat on earnings and sales, Bunge Global raised its full-year 2026 earnings guidance, which Texas Capital Securities highlighted as a key factor in its decision to keep the stock rated Buy with a USD 150 target, according to Investing.com on September 10, 2026. BMO Capital likewise reiterated its Outperform rating with a USD 150 target after investor meetings that focused on topics such as North American crush margins and the integration of Viterra, as reported by Investing.com.

For investors, the combination of a modest earnings beat, higher full-year guidance and continuing integration work on the Viterra deal explains why many banks still see upside despite UBS moving its target down. The consensus target of USD 132.67 cited by MarketBeat suggests room for the stock to climb a further high single-digit percent from recent levels if the company continues delivering on its 2026 plan.

Geopolitical risk: Ukrainian facility reported hit by Russian attacks

Alongside valuation and earnings, geopolitical risk remains a concrete factor in the Bunge Global story. On September 10, 2026, French financial portal Zonebourse reported that renewed Russian strikes on sunflower oil refineries in Ukraine hit a plant belonging to Bunge in the city of Dnipro. According to Zonebourse on September 10, 2026, the report notes that the attacks targeted sunflower oil infrastructure and that a factory owned by Bunge was struck, underscoring the operational and security risks the group faces in frontier markets.

A related report from the same outlet stated that Russian strikes in Dnipro have hit a company belonging to Bunge, according to the citys mayor, again underlining that a portion of the companys asset base is exposed to the conflict, as reported by Zonebourse on September 10, 2026. For shareholders, that adds a tangible risk dimension to the otherwise broadly positive earnings and rating narrative.

Stock trades in the upper part of its one-year range

The valuation discussion is taking place with Bunge Global stock already at an elevated level on the New York Stock Exchange. Per Nasdaq-quoted data compiled by Yahoo Finance, the shares closed at USD 123.50 on September 9, 2026, down 0.31 percent from a previous close of USD 123.89, with an intraday range that stretched from USD 121.92 to USD 126.22 and a volume of about 433,630 shares, as reflected in the historical data overview on Investing.com for September 9, 2026.

The one-year performance frame is also robust. According to Investing.com, the stock price around USD 123.50 corresponds to a gain of 54 percent over the past year, placing the shares clearly closer to the top than to the bottom of their 52-week range. A technical analysis snapshot from Moneycontrol shows a short-term bullish configuration with the relative strength index at 62.87 and several moving-average crossovers in positive territory, according to Moneycontrol on September 10, 2026, suggesting that the trend remains constructive even after the recent pullback.

Based on the September 9, 2026 closing price of USD 123.50 and the consensus price target of USD 132.67 reported by MarketBeat, the stock trades at a discount of around 7.4 percent to the average analyst target, a spread that helps explain why even a cut from UBS has not triggered a wholesale shift to neutral or Sell ratings.

Next dates and investor takeaway

While the latest search results do not flag a specific upcoming quarterly earnings date, the recent Q2 2026 release and the raised full-year guidance mean that investors attention is likely to focus on whether the company can sustain its crush margins and navigate geopolitical disruptions in the second half of 2026. In the meantime, sector commentary around global trade talks and agricultural exports continues to highlight Bunge as a key name to watch alongside peers such as Archer-Daniels-Midland, as noted in a thematic piece on agricultural-export stocks from Investing.com on September 10, 2026.

For retail investors, the picture is therefore a mix of strong recent operational delivery, a share price already much higher than a year ago and external risks ranging from geopolitical shocks in Ukraine to global trade negotiations. The fact that UBS has cut its target to USD 115 while still recommending buying the stock, and that Texas Capital and BMO remain at USD 150, shows that the key question now is how much of the improved earnings path is already priced in at around USD 123.50 per share.

Stock price snapshot and trading venue

As of the most recent completed regular session on September 9, 2026, Bunge Global SA stock closed at USD 123.50 on the New York Stock Exchange, down 0.31 percent on the day in USD terms, with the price sitting in the upper segment of its 52-week range and still below the analyst consensus target of USD 132.67. That NYSE quote in US dollars remains the primary reference for investors tracking Bunge Global.